Citigroup Downgrades Bristol-Myers Squibb (LSE:0R1F)

Fintel reports that on October 25, 2024, Citigroup downgraded their outlook for Bristol-Myers Squibb (LSE:0R1F) from Buy to Neutral. https://www.nasdaq.com/articles/citigroup-downgrades-bristol-myers-squibb-lse-0r1f